A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits

Sponsor
University of Minnesota (Other)
Overall Status
Recruiting
CT.gov ID
NCT04311320
Collaborator
(none)
50
1
1
21.2
2.4

Study Details

Study Description

Brief Summary

Purpose: Using a novel oxygen blender prototype with modified bCPAP to manage children 1 month to 5 years of age hospitalized with respiratory distress due to lower respiratory tract infection (LRTI) in low-resource settings is not associated with clinical failure within 1 hour of use.

Aim: To investigate if this novel oxygen blender is safe to use among children 1 month to 5 years old hospitalized for respiratory distress from lower respiratory tract infections in a low-resource setting.

Condition or Disease Intervention/Treatment Phase
  • Device: Low-Resource Oxygen Blender
N/A

Detailed Description

The study will be a prospective cohort feasibility and safety trial. Patients admitted to Chenla Children's Healthcare who meet eligibility criteria will be asked for consent and then enrolled. Once enrolled, the participant will be treated per hospital protocols and stabilized on bCPAP respiratory support. Once stable for 2 hours, the blender will be incorporated into the bCPAP circuit. At this point, the study nurses will begin recording data for the study as well as providing standard medical care per hospital protocols.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits
Actual Study Start Date :
Mar 26, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Low-Resource Oxygen Blender

This is a single-arm study. All participants will receive respiratory support using the investigational device.

Device: Low-Resource Oxygen Blender
The device that is being evaluated is a novel low-cost, high access oxygen blender designed to be used in the World Health Organization bCPAP design. It functions by utilizing the Venturi effect, whereby a narrow jet of one fluid (i.e. oxygen) creates a suction effect and entrains surrounding ambient fluid (i.e. room air) into the jet, effectively creating a mixed solution of both fluids. The cost of materials amounts to approximately 1.40 U.S.D. The average time it takes to build a blender and incorporate it into a bCPAP circuit for a new user is approximately 16 minutes. The materials can all be found in a standard hospital, namely 3cc syringes with rubber stops and a 22 gauge hypodermic needle.

Outcome Measures

Primary Outcome Measures

  1. Feasibility as Measured by Clinical Failure [1 hour]

    The primary outcome of this study is the feasibility of the investigational device as measured by clinical failure within 1 hour of installing the blender in the bubble continuous positive airway pressure (bCPAP) circuit. Clinical failure is defined as the occurrence of any of the following patient events: intubation, death, or transfer for higher level of care, or any 2 of the following events; <85% O2 saturation after 30 min of treatment, new signs of respiratory distress, or partial pressure of carbon dioxide greater than 60 mmHg and pH less than 7.2 in capillary blood gas. Outcome will be reported as the percent of participants who experience clinical failure within 1 hour after blender installation.

Secondary Outcome Measures

  1. Oxygen Saturation [Approximately 7 days]

    Oxygen saturation will be measured with pulse oximeter every 6 hours for the length of hospital submission. Outcome will be reported as mean of all measurements per patient. Units are percent.

  2. Oxygen Concentration of Outflow [Approximately 7 days]

    Oxygen concentration of outflow from nasal cannula will be measured with an oxygen analyzer every 6 hours for the length of hospital submission. Outcome will be reported as mean of all measurements per patient. Units are percent oxygen.

  3. Flow of Oxygen from Tank [Approximately 7 days]

    Flow of oxygen from tank will be measured with the gauge on the oxygen canister. Measurements will be recorded every 6 hours for the length of hospital submission. Outcome will be reported as mean of all measurements per patient in units of liters per minute.

  4. Continuous Positive Air Pressure (CPAP) Level [Approximately 7 days]

    CPAP level (as displayed on CPAP device) will be recorded every 6 hours for the length of hospital submission. Outcome will be reported as mean of all measurements per patient. This outcome measure is reported in units of cm of H2O.

  5. Bubble Continuous Positive Air Pressure (bCPAP) Maintenance [Approximately 7 days]

    bCPAP maintenance is defined as the number of times no bubbling in the water column is noted by study staff indicating the need for maintenance. Need for maintenance will be assessed every 2 hours for the length of hospital stay. Number of incidents per patient will be recorded and outcome will be reported as a mean value of all measurements per patient.

  6. Blender Maintenance [Approximately 7 days]

    Blender maintenance is defined as the number of times the blender needs to be repaired or replaced per patient. Need for maintenance will be assessed every 2 hours for the length of hospital stay. Number of incidents per patient will be recorded and outcome will be reported as mean value of all measurements per patient.

  7. Duration of Respiratory Support [Approximately 7 days]

    Outcome will be reported as the length of time (in hours) that respiratory support (i.e. requiring bCPAP and blender) is required during hospital submission.

  8. Number of Patient Transfers [Approximately 7 days]

    Outcome is reported as number of patients who require transfer to a higher level of care.

  9. Number of Patient Intubations [Approximately 7 days]

    Outcome is reported as number of patients requiring intubation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Days to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admitted for lung disease and require hospitalization

  • Admission diagnosis is lower respiratory tract infection or pneumonia or bronchiolitis (any infectious microbe including bacterial, viral, fungal, parasitic)

  • Have respiratory distress on presentation to the hospital (cough or trouble breathing plus at least one of the following: <92% despite low flow oxygen, central cyanosis, tachypnea, chest indrawing, nasal flaring, grunting, head nodding, convulsions, lethargy, inability to breastfeed or drink)

  • A bCPAP (electronic) machine is not available to use

Exclusion Criteria:
  • History of asthma

  • Upper airway obstruction

  • Diaphragmatic hernia

  • Pneumothorax

  • Acute Glasgow Coma score <4

  • Cleft Palate

  • Cyanotic heart disease

  • Bleeding disorders

  • Imminent death within 2 hours

  • Have had abdominal or thoracic surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chenla Children's Healthcare Kratié Kratié Province Cambodia 10109

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: Andrew Wu, MD, MPH, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT04311320
Other Study ID Numbers:
  • STUDY00008434
First Posted:
Mar 17, 2020
Last Update Posted:
Aug 22, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2022